Skip to main content
Top
Published in: Endocrine 3/2017

01-09-2017 | Original Article

Circulating anti-Müllerian hormone (AMH) associates with the maturity of boys’ drawings: Does AMH slow cognitive development in males?

Authors: Kirstie Morgan, Ted Ruffman, David K. Bilkey, Ian S. McLennan

Published in: Endocrine | Issue 3/2017

Login to get access

Abstract

Purpose

High levels of circulating anti-Müllerian hormone are unique to developing males, but the function of anti-Müllerian hormone in boys is unknown. In mice, anti-Müllerian hormone contributes to the male biases in the brain, but its receptors are present throughout non-sexually dimorphic portions of the brain. In humans, the speed of maturation is the most overt difference between girls and boys. We postulate that this is because anti-Müllerian hormone slows the maturation of the male human brain.

Methods

One hundred and fourty three 5-year or 6-year-old boys and 38 age-matched girls drew a person and donated a blood sample. The children’s drawings were blind-scored to generate a maturity index. The level of anti-Müllerian hormone and the other Sertoli cell hormone, inhibin B, were measured by ELISA. The relationship between the children’s age, hormones and maturity index were examined by linear regression analysis.

Results

The girls drew more complex and realistic person than the boys (32%, p = 0.001), with their drawings also being larger (39%, p = 0.037) and more coloured-in (235%, p = 0.0005). The maturity index in boys correlated with age (+r = 0.43, p < 0.0005) and anti-Müllerian hormone level (−r = −0.29, p < 0.0005). The association between maturity index and anti-Müllerian hormone level persisted when corrected for age and for inhibin B (r = −0.24, p = 0.0005). The calculated effect of the median level of anti-Müllerian hormone (1 nM) was equal to 0.81 months of development. The size and colouring of the drawings did not correlate with the boys’ age, anti-Müllerian hormone or inhibin B.

Conclusions

This exploratory study provides the first indicative evidence that circulating anti-Müllerian hormone may influence the development of the human brain.
Literature
1.
go back to reference D.T. MacLaughlin, P.K. Donahoe, Sex determination and differentiation. New Eng. J. Med. 350, 367–378 (2004)CrossRefPubMed D.T. MacLaughlin, P.K. Donahoe, Sex determination and differentiation. New Eng. J. Med. 350, 367–378 (2004)CrossRefPubMed
2.
go back to reference M.M. Lee, P.K. Donahoe, T. Hasegawa, B. Silverman, G.B. Crist, S. Best, Y. Hasegawa, R.A. Noto, D. Schoenfeld, D.T. MacLaughlin, Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 81, 571–576 (1996)PubMed M.M. Lee, P.K. Donahoe, T. Hasegawa, B. Silverman, G.B. Crist, S. Best, Y. Hasegawa, R.A. Noto, D. Schoenfeld, D.T. MacLaughlin, Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 81, 571–576 (1996)PubMed
3.
go back to reference L. Aksglaede, K. Sorensen, M. Boas, A. Mouritsen, C.P. Hagen, R.B. Jensen, J.H. Petersen, A. Linneberg, A.M. Andersson, K.M. Main, N.E. Skakkebaek, A. Juul, Changes in anti-mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J. Clin. Endocrinol. Metab. 95, 5357–5364 (2010)CrossRefPubMed L. Aksglaede, K. Sorensen, M. Boas, A. Mouritsen, C.P. Hagen, R.B. Jensen, J.H. Petersen, A. Linneberg, A.M. Andersson, K.M. Main, N.E. Skakkebaek, A. Juul, Changes in anti-mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J. Clin. Endocrinol. Metab. 95, 5357–5364 (2010)CrossRefPubMed
4.
go back to reference N. Josso, Evolution of the mullerian-inhibiting activity of the human testis. Effect of fetal, peri-natal and post-natal human testicular tissue on the mullerian duct of the fetal rat in organ culture. Biol. Neonate. 20, 368–379 (1972)CrossRefPubMed N. Josso, Evolution of the mullerian-inhibiting activity of the human testis. Effect of fetal, peri-natal and post-natal human testicular tissue on the mullerian duct of the fetal rat in organ culture. Biol. Neonate. 20, 368–379 (1972)CrossRefPubMed
5.
go back to reference C.P. Hagen, L. Aksglaede, K. Sorensen, K.M. Main, M. Boas, L. Cleemann, K. Holm, C.H. Gravholt, A.M. Andersson, A.T. Pedersen, J.H. Petersen, A. Linneberg, S. Kjaergaard, A. Juul, Serum levels of anti-mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients. J. Clin. Endocrinol. Metab. 95, 5003–5010 (2010)CrossRefPubMed C.P. Hagen, L. Aksglaede, K. Sorensen, K.M. Main, M. Boas, L. Cleemann, K. Holm, C.H. Gravholt, A.M. Andersson, A.T. Pedersen, J.H. Petersen, A. Linneberg, S. Kjaergaard, A. Juul, Serum levels of anti-mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients. J. Clin. Endocrinol. Metab. 95, 5003–5010 (2010)CrossRefPubMed
6.
go back to reference M.W. Pankhurst, I.S. McLennan, Inhibin b and anti-mullerian hormone/mullerian-inhibiting substance may contribute to the male bias in autism. Transl. Psychiatry 2, e148 (2012)CrossRefPubMedCentral M.W. Pankhurst, I.S. McLennan, Inhibin b and anti-mullerian hormone/mullerian-inhibiting substance may contribute to the male bias in autism. Transl. Psychiatry 2, e148 (2012)CrossRefPubMedCentral
8.
go back to reference Y. Shi, J. Massague, Mechanisms of tgf-beta signaling from cell membrane to the nucleus. Cell 113, 685–700 (2003)CrossRefPubMed Y. Shi, J. Massague, Mechanisms of tgf-beta signaling from cell membrane to the nucleus. Cell 113, 685–700 (2003)CrossRefPubMed
9.
go back to reference G.D. Orvis, S.P. Jamin, K.M. Kwan, Y. Mishina, V.M. Kaartinen, S. Huang, A.B. Roberts, L. Umans, D. Huylebroeck, A. Zwijsen, D. Wang, J.F. Martin, R.R. Behringer, Functional redundancy of tgf-beta family type i receptors and receptor-smads in mediating anti-mullerian hormone-induced müllerian duct regression in the mouse. Biol. Reprod. 78, 994–1001 (2008)CrossRefPubMedPubMedCentral G.D. Orvis, S.P. Jamin, K.M. Kwan, Y. Mishina, V.M. Kaartinen, S. Huang, A.B. Roberts, L. Umans, D. Huylebroeck, A. Zwijsen, D. Wang, J.F. Martin, R.R. Behringer, Functional redundancy of tgf-beta family type i receptors and receptor-smads in mediating anti-mullerian hormone-induced müllerian duct regression in the mouse. Biol. Reprod. 78, 994–1001 (2008)CrossRefPubMedPubMedCentral
10.
go back to reference E. Bier, E.M. De Robertis, Embryo development. Bmp gradients: a paradigm for morphogen-mediated developmental patterning. Science 348, aaa5838 (2015)CrossRefPubMed E. Bier, E.M. De Robertis, Embryo development. Bmp gradients: a paradigm for morphogen-mediated developmental patterning. Science 348, aaa5838 (2015)CrossRefPubMed
11.
go back to reference I.S. McLennan, M.W. Pankhurst, Anti-mullerian hormone is a gonadal cytokine with two circulating forms and cryptic actions. J. Endocrinol. 226, R45–R57 (2015)CrossRefPubMed I.S. McLennan, M.W. Pankhurst, Anti-mullerian hormone is a gonadal cytokine with two circulating forms and cryptic actions. J. Endocrinol. 226, R45–R57 (2015)CrossRefPubMed
12.
go back to reference W. Wittmann, I.S. McLennan, The male bias in the number of purkinje cells and the size of the murine cerebellum may require mullerian inhibiting substance/anti-mullerian hormone. J. Neuroendocrinol. 23, 831–838 (2011)CrossRefPubMed W. Wittmann, I.S. McLennan, The male bias in the number of purkinje cells and the size of the murine cerebellum may require mullerian inhibiting substance/anti-mullerian hormone. J. Neuroendocrinol. 23, 831–838 (2011)CrossRefPubMed
13.
go back to reference W. Wittmann, I.S. McLennan, Anti-mullerian hormone may regulate the number of calbindin-positive neurons in the sexually dimorphic nucleus of the preoptic area of male mice. Biol. Sex Differ. 4, 18 (2013)CrossRefPubMedPubMedCentral W. Wittmann, I.S. McLennan, Anti-mullerian hormone may regulate the number of calbindin-positive neurons in the sexually dimorphic nucleus of the preoptic area of male mice. Biol. Sex Differ. 4, 18 (2013)CrossRefPubMedPubMedCentral
14.
go back to reference W. Wittmann, I.S. McLennan, The bed nucleus of the stria terminalis has developmental and adult forms in mice, with the male bias in the developmental form being dependent on testicular AMH. Horm. Behav. 64, 605–610 (2013)CrossRefPubMed W. Wittmann, I.S. McLennan, The bed nucleus of the stria terminalis has developmental and adult forms in mice, with the male bias in the developmental form being dependent on testicular AMH. Horm. Behav. 64, 605–610 (2013)CrossRefPubMed
15.
go back to reference P.Y. Wang, A. Protheroe, A.N. Clarkson, F. Imhoff, K. Koishi, I.S. McLennan, Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc. Natl Acad. Sci. USA 106, 7203–7208 (2009)CrossRefPubMedPubMedCentral P.Y. Wang, A. Protheroe, A.N. Clarkson, F. Imhoff, K. Koishi, I.S. McLennan, Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc. Natl Acad. Sci. USA 106, 7203–7208 (2009)CrossRefPubMedPubMedCentral
16.
go back to reference K. Morgan, J. Meredith, J.-Y.A. Kuo, D.K. Bilkey, I.S. McLennan, The sex bias in novelty preference of preadolescent mouse pups may require testicular müllerian inhibiting substance. Behav. Brain Res. 221, 304–306 (2011)CrossRefPubMed K. Morgan, J. Meredith, J.-Y.A. Kuo, D.K. Bilkey, I.S. McLennan, The sex bias in novelty preference of preadolescent mouse pups may require testicular müllerian inhibiting substance. Behav. Brain Res. 221, 304–306 (2011)CrossRefPubMed
17.
go back to reference F. Pfennig, A. Standke, H.O. Gutzeit, The role of amh signaling in teleost fish--multiple functions not restricted to the gonads. Gen. Comp. Endocrinol. 223, 87–107 (2015)CrossRefPubMed F. Pfennig, A. Standke, H.O. Gutzeit, The role of amh signaling in teleost fish--multiple functions not restricted to the gonads. Gen. Comp. Endocrinol. 223, 87–107 (2015)CrossRefPubMed
18.
go back to reference J.M. Tanner, P.S. Davies, Clinical longitudinal standards for height and height velocity for north american children. J. Pediatr. 107, 317–329 (1985)CrossRef J.M. Tanner, P.S. Davies, Clinical longitudinal standards for height and height velocity for north american children. J. Pediatr. 107, 317–329 (1985)CrossRef
19.
20.
go back to reference A.N. Clarkson, C.L. Talbot, P.Y. Wang, D.T. Maclaughlin, P.K. Donahoe, I.S. McLennan, Mullerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neurons. Exp. Neurol. 231, 304–308 (2011)CrossRefPubMed A.N. Clarkson, C.L. Talbot, P.Y. Wang, D.T. Maclaughlin, P.K. Donahoe, I.S. McLennan, Mullerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neurons. Exp. Neurol. 231, 304–308 (2011)CrossRefPubMed
21.
go back to reference Cox, MV, Children’s drawing of the human figure. Essays in developmental psychology. (Psychology Press, Lawrence Erlbaum Associates, Hove, UK, 1993) Cox, MV, Children’s drawing of the human figure. Essays in developmental psychology. (Psychology Press, Lawrence Erlbaum Associates, Hove, UK, 1993)
22.
go back to reference K. Morgan, N.A. Dennis, T. Ruffman, Dk Bilkey, I.S. McLennan, The stature of boys is inversely correlated to the levels of their sertoli cell hormones: do the testes restrain the maturation of boys? PLoS ONE 6, e20533 (2011)CrossRefPubMedPubMedCentral K. Morgan, N.A. Dennis, T. Ruffman, Dk Bilkey, I.S. McLennan, The stature of boys is inversely correlated to the levels of their sertoli cell hormones: do the testes restrain the maturation of boys? PLoS ONE 6, e20533 (2011)CrossRefPubMedPubMedCentral
23.
go back to reference C.R. Reynolds, J.A. Hickman. Draw-a-person intellectual ability test for children, adolescents, and adults examiner’s manual. (Pro-Ed, Austin, TX, 2004) C.R. Reynolds, J.A. Hickman. Draw-a-person intellectual ability test for children, adolescents, and adults examiner’s manual. (Pro-Ed, Austin, TX, 2004)
24.
go back to reference G. Griesinger, K. Dafopoulos, N. Buendgen, I. Cascorbi, P. Georgoulias, A. Zavos, C.I. Messini, I.E. Messinis, Elimination half-life of anti-Müllerian hormone. J. Clin. Endocrinol. Metab. 97, 2160–2163 (2012)CrossRefPubMed G. Griesinger, K. Dafopoulos, N. Buendgen, I. Cascorbi, P. Georgoulias, A. Zavos, C.I. Messini, I.E. Messinis, Elimination half-life of anti-Müllerian hormone. J. Clin. Endocrinol. Metab. 97, 2160–2163 (2012)CrossRefPubMed
25.
go back to reference L. Bungum, A.K. Jacobsson, F. Rosen, C. Becker, C. Yding Andersen, N. Guner, A. Giwercman, Circadian variation in concentration of anti-mullerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels. Hum. Reprod. 26, 678–684 (2011)CrossRefPubMed L. Bungum, A.K. Jacobsson, F. Rosen, C. Becker, C. Yding Andersen, N. Guner, A. Giwercman, Circadian variation in concentration of anti-mullerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levels. Hum. Reprod. 26, 678–684 (2011)CrossRefPubMed
26.
go back to reference Y.H. Chong, M.W. Pankhurst, I.S. McLennan, The daily profiles of circulating AMH and insl3 in men are distinct from the other testicular hormones, inhibin b and testosterone. PLoS ONE 10, e0133637 (2015)CrossRefPubMedPubMedCentral Y.H. Chong, M.W. Pankhurst, I.S. McLennan, The daily profiles of circulating AMH and insl3 in men are distinct from the other testicular hormones, inhibin b and testosterone. PLoS ONE 10, e0133637 (2015)CrossRefPubMedPubMedCentral
27.
go back to reference A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, N.S. Macklon, Anti-mullerian hormone (AMH): what do we still need to know? Hum. Reprod. 24, 2264–2275 (2009)CrossRefPubMed A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, N.S. Macklon, Anti-mullerian hormone (AMH): what do we still need to know? Hum. Reprod. 24, 2264–2275 (2009)CrossRefPubMed
28.
go back to reference N.A. Dennis, G.T. Jones, Y.H. Chong, A.M. van Rij, I.S. McLennan, Serum anti-mullerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: is AMH a cardiovascular hormone? J. Endocrinol. 219, 13–20 (2013)CrossRefPubMed N.A. Dennis, G.T. Jones, Y.H. Chong, A.M. van Rij, I.S. McLennan, Serum anti-mullerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: is AMH a cardiovascular hormone? J. Endocrinol. 219, 13–20 (2013)CrossRefPubMed
29.
go back to reference J. Teixeira, W.W. He, P.C. Shah, N. Morikawa, M.M. Lee, E.A. Catlin, P.L. Hudson, J. Wing, D.T. Maclaughlin, P.K. Donahoe, Developmental expression of a candidate mullerian inhibiting substance type ii receptor. Endocrinology 137, 160–165 (1996)CrossRefPubMed J. Teixeira, W.W. He, P.C. Shah, N. Morikawa, M.M. Lee, E.A. Catlin, P.L. Hudson, J. Wing, D.T. Maclaughlin, P.K. Donahoe, Developmental expression of a candidate mullerian inhibiting substance type ii receptor. Endocrinology 137, 160–165 (1996)CrossRefPubMed
30.
go back to reference P.Y. Wang, K. Koishi, A.B. McGeachie, M. Kimber, D.T. Maclaughlin, P.K. Donahoe, I.S. McLennan, Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc. Natl Acad. Sci. USA 102, 16421–16425 (2005)CrossRefPubMedPubMedCentral P.Y. Wang, K. Koishi, A.B. McGeachie, M. Kimber, D.T. Maclaughlin, P.K. Donahoe, I.S. McLennan, Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc. Natl Acad. Sci. USA 102, 16421–16425 (2005)CrossRefPubMedPubMedCentral
31.
go back to reference A. Liu, L.A. Niswander, Bone morphogenetic protein signalling and vertebrate nervous system development. Nat. Rev. Neurosci. 6, 945–954 (2005)CrossRefPubMed A. Liu, L.A. Niswander, Bone morphogenetic protein signalling and vertebrate nervous system development. Nat. Rev. Neurosci. 6, 945–954 (2005)CrossRefPubMed
32.
go back to reference E.A. Catlin, S.M. Powell, T.F. Manganaro, P.L. Hudson, R.C. Ragin, J. Epstein, P.K. Donahoe, Sex-specific fetal lung development and mullerian inhibiting substance. Am. Rev. Respir. Dis. 141, 466–470 (1990)CrossRefPubMed E.A. Catlin, S.M. Powell, T.F. Manganaro, P.L. Hudson, R.C. Ragin, J. Epstein, P.K. Donahoe, Sex-specific fetal lung development and mullerian inhibiting substance. Am. Rev. Respir. Dis. 141, 466–470 (1990)CrossRefPubMed
33.
go back to reference S.E. Appt, H. Chen, T.B. Clarkson, J.R. Kaplan, Premenopausal antimullerian hormone concentration is associated with subsequent atherosclerosis. Menopause 19, 1353–1359 (2012)CrossRefPubMedPubMedCentral S.E. Appt, H. Chen, T.B. Clarkson, J.R. Kaplan, Premenopausal antimullerian hormone concentration is associated with subsequent atherosclerosis. Menopause 19, 1353–1359 (2012)CrossRefPubMedPubMedCentral
34.
go back to reference R. Anand-Ivell, R. Ivell, D. Driscoll, J. Manson, Insulin-like factor 3 levels in amniotic fluid of human male fetuses. Hum. Reprod. 23, 1180–1186 (2008)CrossRefPubMed R. Anand-Ivell, R. Ivell, D. Driscoll, J. Manson, Insulin-like factor 3 levels in amniotic fluid of human male fetuses. Hum. Reprod. 23, 1180–1186 (2008)CrossRefPubMed
35.
go back to reference K. Bay, H.E. Virtanen, S. Hartung, R. Ivell, K.M. Main, N.E. Skakkebaek, A.M. Andersson, J. Toppari, Insulin-like factor 3 levels in cord blood and serum from children: Effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism. J. Clin. Endocrinol. Metab. 92, 4020–4027 (2007)CrossRefPubMed K. Bay, H.E. Virtanen, S. Hartung, R. Ivell, K.M. Main, N.E. Skakkebaek, A.M. Andersson, J. Toppari, Insulin-like factor 3 levels in cord blood and serum from children: Effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism. J. Clin. Endocrinol. Metab. 92, 4020–4027 (2007)CrossRefPubMed
37.
go back to reference M.W. Pankhurst, I.S. McLennan, Human blood contains both the uncleaved precursor of anti-mullerian hormone and a complex of the nh2- and cooh-terminal peptides. Am. J. Physiol. Endocrinol. Metab. 305, E1241–E1247 (2013)CrossRefPubMed M.W. Pankhurst, I.S. McLennan, Human blood contains both the uncleaved precursor of anti-mullerian hormone and a complex of the nh2- and cooh-terminal peptides. Am. J. Physiol. Endocrinol. Metab. 305, E1241–E1247 (2013)CrossRefPubMed
38.
go back to reference M.W. Pankhurst, Y.H. Chong, I.S. McLennan, Enzyme-linked immunosorbent assay measurements of antimullerian hormone (AMH) in human blood are a composite of the uncleaved and bioactive cleaved forms of AMH. Fertil. Steril. 101, 846–850 (2014)CrossRefPubMed M.W. Pankhurst, Y.H. Chong, I.S. McLennan, Enzyme-linked immunosorbent assay measurements of antimullerian hormone (AMH) in human blood are a composite of the uncleaved and bioactive cleaved forms of AMH. Fertil. Steril. 101, 846–850 (2014)CrossRefPubMed
Metadata
Title
Circulating anti-Müllerian hormone (AMH) associates with the maturity of boys’ drawings: Does AMH slow cognitive development in males?
Authors
Kirstie Morgan
Ted Ruffman
David K. Bilkey
Ian S. McLennan
Publication date
01-09-2017
Publisher
Springer US
Published in
Endocrine / Issue 3/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1333-2

Other articles of this Issue 3/2017

Endocrine 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.